Aaron Green - 07 Nov 2023 Form 3 Insider Report for OneMedNet Corp (ONMD)

Role
Chief Executive Officer, Director
Signature
/s/ Aaron Green
Issuer symbol
ONMD
Transactions as of
07 Nov 2023
Transactions value $
$0
Form type
3
Filing time
26 Nov 2025, 21:49:37 UTC
Next filing
26 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Green Aaron Chief Executive Officer, Director 6385 OLD SHADY OAK ROAD, SUITE 250, EDEN PRAIRIE /s/ Aaron Green 26 Nov 2025 0001990275

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ONMD Common Stock 600K 07 Nov 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ONMD Senior Secured Convertible Note 07 Nov 2023 Common Stock $266K $10.00 Direct F2
holding ONMD Warrants (Right to Buy) 07 Nov 2023 Common Stock 16K $10.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted to the reporting person on May 1, 2023 under the OneMedNet Corporation 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments over 24 months thereafter, subject to the reporting person's continued service with the issuer through the vesting date.
F2 On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price. The PIPE Notes mature on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes.
F3 The warrants are immediately exercisable, and the exercise price is subject to anti-dilution adjustment.

Remarks:

Exhibit 24 - POWER OF ATTORNEY